540 likes | 743 Views
ITFG. . The Inhalation Technology Focus Group (ITFG) of the American Association of Pharmaceutical Scientists is comprised of pharmaceutical scientists who seek to foster and advance the art and science of pharmaceutical aerosol products, aerosol technology and related processes . Introduction.
E N D
1. OVERVIEW OFITFG/IPAC COLLABORATION Presented by: Harris Cummings, PhD26 April 2000Rockville, MD
2. ITFG
3. IPAC
9. 3M Pharmaceuticals
Agouron
Aradigm
AstraZeneca
Aventis
Bespak
BI Roxane
Boehringer Ingelheim
Dura Pharmaceuticals
Eli Lilly
Glaxo Wellcome
Inhale Therapeutic Systems Inspire Pharmaceuticals
IVAX
Kos Pharmaceuticals
Lovelace Respiratory Institute
Magellan Laboratories
Pfeiffer
Presspart
Primedica
Schering-Plough
Trudell Medical
University of Rhode Island
Valois
12. ITFG/IPAC TECHNICAL TEAM: BA/BE IN VITRO AND IN VIVO TESTSPresented by: Stephen Farr, PhD 26 April 2000Rockville, MD
17. ITFG/IPAC TECHNICAL TEAM: CMC SPECIFICATIONSPresented by: Bo Olsson, PhD26 April 2000Rockville, MD
30. ITFG/IPAC TECHNICAL TEAM: CMC LEACHABLES AND EXTRACTABLESPresented by: Kaushik J. Dave, R.Ph, PhD26 April 2000Rockville, MD
39. ITFG/IPAC TECHNICAL TEAM: SUPPLIER QUALITY CONTROL (QUALIFICATION)Presented by: Gordon Hansen26 April 2000Rockville, MD Thank you and good morning. I’d like to take the next few minutes to present an overview of the Supplier Quality Control/Qualification team.Thank you and good morning. I’d like to take the next few minutes to present an overview of the Supplier Quality Control/Qualification team.
40. This team has presented a unique opportunity for representatives from the pharma companies and component suppliers to collaborate on issues which are central to our industryThis team has presented a unique opportunity for representatives from the pharma companies and component suppliers to collaborate on issues which are central to our industry
41. The team has thoroughly reviewedThe team has thoroughly reviewed
48. ITFG/IPAC COLLABORATION: CONCLUDING REMARKSPresented by: Cynthia Flynn, PhD26 April 2000Rockville, MD
53. PARTICIPANTS
54. PARTICIPANTS
55. PARTICIPANTS